0001171843-24-000431.txt : 20240126 0001171843-24-000431.hdr.sgml : 20240126 20240126161021 ACCESSION NUMBER: 0001171843-24-000431 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 13 CONFORMED PERIOD OF REPORT: 20240122 ITEM INFORMATION: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers FILED AS OF DATE: 20240126 DATE AS OF CHANGE: 20240126 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PSYCHEMEDICS CORP CENTRAL INDEX KEY: 0000806517 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] ORGANIZATION NAME: 08 Industrial Applications and Services IRS NUMBER: 581701987 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-13738 FILM NUMBER: 24567837 BUSINESS ADDRESS: STREET 1: 125 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 BUSINESS PHONE: 978-206-8220 MAIL ADDRESS: STREET 1: 125 NAGOG PARK CITY: ACTON STATE: MA ZIP: 01720 8-K 1 f8k_012624.htm FORM 8-K
false 0000806517 0000806517 2024-01-22 2024-01-22 0000806517 dei:FormerAddressMember 2024-01-22 2024-01-22 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): January 22, 2024

 

PSYCHEMEDICS CORPORATION

(Exact Name of Registrant as Specified in its Charter)

 

Delaware 1-13738 58-1701987
(State or Other Jurisdiction of Incorporation) (Commission File Number) (I.R.S. Employer Identification No.)

 

  5220 Spring Valley Road, Suite 230, Dallas, TX 75254
  (Address of Principal Executive Offices) (Zip Code)

 

(800) 522-7424

(Registrant’s Telephone Number, Including Area Code)

 

289 Great Road, Acton, Massachusetts 01720

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instructions A.2. below):

 

☐   Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
☐ Pre-commencement communications pursuant to Rule 13e4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Class Trading Symbol(s) Name of each exchange on which registered
Common stock. $0.005 par value PMD The NASDAQ Stock Market, LLC.

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ☐

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

 

 

 

ITEM 5.02 DEPARTURE OF DIRECTORS OR CERTAIN OFFICERS; ELECTION OF DIRECTORS; APPOINTMENT OF CERTAIN OFFICERS; COMPENSATORY ARRANGEMENTS OF CERTAIN OFFICERS

 

(e)       On January 22, 2024, the Compensation Committee of the Board of Directors of the Corporation approved the terms of cash performance bonus arrangements.

 

2024 Chief Executive Officer’s Performance Bonus Plan

 

At the January 22, 2024 meeting, the Compensation Committee approved a 2024 cash bonus plan for Brian Hullinger, the Corporation’s Chief Executive Officer, that includes corporate financial performance targets and individual performance goals. The overall targeted bonus established under this plan is $190,000, with a maximum amount of $285,000. The actual bonus award, if any, will be determined based upon the level of achievement of the established performance targets and goals as determined by the Compensation Committee.

 

2024 Other Executive Officer Cash Bonus Plan

 

Also at its January, 22, 2024 meeting, the Compensation Committee approved a 2024 cash bonus plan for other executive officers corporate that includes financial performance targets and individual performance goals. The target amounts of such cash bonuses range from 25% to 40% of base salary for each of the officers. The actual amount of each cash bonus, if any, will be subject to increase or decrease at the discretion of the Compensation Committee.

 

Following the end of fiscal year 2024, the Chief Executive Officer will review and assess the performance of each of the other participants with respect to achievement of his or her individual goals and provide his recommendations thereon to the Compensation Committee. In addition, the Compensation Committee will review and assess the Chief Executive Officer's performance with respect to achievement of his individual goals. The Compensation Committee will then determine the level of payout of the portion of the Chief Executive Officer’s bonus arrangement with respect to individual and company goals, and each of the other participants, based on the Committee's review and assessment of the performance of each individual toward his or her individual goals and company goals.

 

 

 

 

 

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  PSYCHEMEDICS CORPORATION
Dated: January 26, 2024  
   
   
  By: /s/ Daniella Mehalik             
    Daniella Mehalik, Vice President - Finance
   

 

 

 EX-101.SCH 2 pmd-20240122.xsd XBRL SCHEMA FILE 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.DEF 3 pmd-20240122_def.xml XBRL DEFINITION FILE EX-101.LAB 4 pmd-20240122_lab.xml XBRL LABEL FILE Entity Addresses, Address Type [Axis] Former Address [Member] Entity Addresses [Table] Entity Addresses [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 5 pmd-20240122_pre.xml XBRL PRESENTATION FILE XML 6 R1.htm IDEA: XBRL DOCUMENT v3.23.4
Cover
Jan. 22, 2024
Entity Addresses [Line Items]  
Document Type 8-K
Amendment Flag false
Document Period End Date Jan. 22, 2024
Entity File Number 1-13738
Entity Registrant Name PSYCHEMEDICS CORPORATION
Entity Central Index Key 0000806517
Entity Tax Identification Number 58-1701987
Entity Incorporation, State or Country Code DE
Entity Address, Address Line One 5220 Spring Valley Road
Entity Address, Address Line Two Suite 230
Entity Address, City or Town Dallas
Entity Address, State or Province TX
Entity Address, Postal Zip Code 75254
City Area Code (800)
Local Phone Number 522-7424
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common stock. $0.005 par value
Trading Symbol PMD
Security Exchange Name NASDAQ
Entity Emerging Growth Company false
Former Address [Member]  
Entity Addresses [Line Items]  
Entity Address, Address Line One 289 Great Road
Entity Address, City or Town Acton
Entity Address, State or Province MA
Entity Address, Postal Zip Code 01720
XML 7 f8k_012624_htm.xml IDEA: XBRL DOCUMENT 0000806517 2024-01-22 2024-01-22 0000806517 dei:FormerAddressMember 2024-01-22 2024-01-22 iso4217:USD shares iso4217:USD shares false 0000806517 8-K 2024-01-22 PSYCHEMEDICS CORPORATION DE 1-13738 58-1701987 5220 Spring Valley Road Suite 230 Dallas TX 75254 (800) 522-7424 289 Great Road Acton MA 01720 false false false false Common stock. $0.005 par value PMD NASDAQ false EXCEL 8 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 9 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 10 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 11 FilingSummary.xml IDEA: XBRL DOCUMENT 3.23.4 html 2 23 1 false 1 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://psychemedics.com/role/Cover Cover Cover 1 false false All Reports Book All Reports f8k_012624.htm pmd-20240122.xsd pmd-20240122_def.xml pmd-20240122_lab.xml pmd-20240122_pre.xml http://xbrl.sec.gov/dei/2023 true false JSON 13 MetaLinks.json IDEA: XBRL DOCUMENT { "version": "2.2", "instance": { "f8k_012624.htm": { "nsprefix": "PMD", "nsuri": "http://psychemedics.com/20240122", "dts": { "inline": { "local": [ "f8k_012624.htm" ] }, "schema": { "local": [ "pmd-20240122.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd", "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd", "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-roles-2023.xsd", "https://xbrl.fasb.org/srt/2023/elts/srt-types-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-gaap-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-roles-2023.xsd", "https://xbrl.fasb.org/us-gaap/2023/elts/us-types-2023.xsd", "https://xbrl.sec.gov/country/2023/country-2023.xsd", "https://xbrl.sec.gov/dei/2023/dei-2023.xsd" ] }, "definitionLink": { "local": [ "pmd-20240122_def.xml" ] }, "labelLink": { "local": [ "pmd-20240122_lab.xml" ] }, "presentationLink": { "local": [ "pmd-20240122_pre.xml" ] } }, "keyStandard": 23, "keyCustom": 0, "axisStandard": 1, "axisCustom": 0, "memberStandard": 1, "memberCustom": 0, "hidden": { "total": 2, "http://xbrl.sec.gov/dei/2023": 2 }, "contextCount": 2, "entityCount": 1, "segmentCount": 1, "elementCount": 64, "unitCount": 3, "baseTaxonomies": { "http://xbrl.sec.gov/dei/2023": 27 }, "report": { "R1": { "role": "http://psychemedics.com/role/Cover", "longName": "00000001 - Document - Cover", "shortName": "Cover", "isDefault": "true", "groupType": "document", "subGroupType": "", "menuCat": "Cover", "order": "1", "firstAnchor": { "contextRef": "AsOf2024-01-22", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "f8k_012624.htm", "first": true, "unique": true }, "uniqueAnchor": { "contextRef": "AsOf2024-01-22", "name": "dei:DocumentType", "unitRef": null, "xsiNil": "false", "lang": "en-US", "decimals": null, "ancestors": [ "span", "span", "p", "body", "html" ], "reportCount": 1, "baseRef": "f8k_012624.htm", "first": true, "unique": true } } }, "tag": { "dei_EntityAddressesLineItems": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesLineItems", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Line Items]", "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table." } } }, "auth_ref": [] }, "dei_Security12bTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12bTitle", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(b) Security", "documentation": "Title of a 12(b) registered security." } } }, "auth_ref": [ "r1" ] }, "dei_DocumentFiscalPeriodFocus": { "xbrltype": "fiscalPeriodItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalPeriodFocus", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Period Focus", "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY." } } }, "auth_ref": [] }, "dei_EntityPrimarySicNumber": { "xbrltype": "sicNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPrimarySicNumber", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Primary SIC Number", "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentAccountingStandard": { "xbrltype": "accountingStandardItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAccountingStandard", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Accounting Standard", "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'." } } }, "auth_ref": [ "r14" ] }, "dei_EntityAddressAddressLine2": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine2", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Two", "documentation": "Address Line 2 such as Street or Suite number" } } }, "auth_ref": [] }, "dei_DocumentPeriodEndDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodEndDate", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period End Date", "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD." } } }, "auth_ref": [] }, "dei_EntitySmallBusiness": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntitySmallBusiness", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Small Business", "documentation": "Indicates that the company is a Smaller Reporting Company (SRC)." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressPostalZipCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressPostalZipCode", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Postal Zip Code", "documentation": "Code for the postal or zip code" } } }, "auth_ref": [] }, "dei_EntityVoluntaryFilers": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityVoluntaryFilers", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Voluntary Filers", "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act." } } }, "auth_ref": [] }, "dei_CityAreaCode": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CityAreaCode", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "City Area Code", "documentation": "Area code of city" } } }, "auth_ref": [] }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "xbrltype": "textBlockItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentsIncorporatedByReferenceTextBlock", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Documents Incorporated by Reference [Text Block]", "documentation": "Documents incorporated by reference." } } }, "auth_ref": [ "r3" ] }, "dei_NoTradingSymbolFlag": { "xbrltype": "trueItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "NoTradingSymbolFlag", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "No Trading Symbol Flag", "documentation": "Boolean flag that is true only for a security having no trading symbol." } } }, "auth_ref": [] }, "dei_EntityExTransitionPeriod": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityExTransitionPeriod", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Elected Not To Use the Extended Transition Period", "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards." } } }, "auth_ref": [ "r21" ] }, "dei_EntityWellKnownSeasonedIssuer": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityWellKnownSeasonedIssuer", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Well-known Seasoned Issuer", "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A." } } }, "auth_ref": [ "r19" ] }, "dei_TradingSymbol": { "xbrltype": "tradingSymbolItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "TradingSymbol", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Trading Symbol", "documentation": "Trading symbol of an instrument as listed on an exchange." } } }, "auth_ref": [] }, "dei_CountryRegion": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CountryRegion", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Country Region", "documentation": "Region code of country" } } }, "auth_ref": [] }, "dei_SecurityExchangeName": { "xbrltype": "edgarExchangeCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityExchangeName", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Exchange Name", "documentation": "Name of the Exchange on which a security is registered." } } }, "auth_ref": [ "r4" ] }, "dei_AuditedAnnualFinancialStatements": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AuditedAnnualFinancialStatements", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Audited Annual Financial Statements", "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements." } } }, "auth_ref": [ "r15" ] }, "dei_SolicitingMaterial": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SolicitingMaterial", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Soliciting Material", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act." } } }, "auth_ref": [ "r10" ] }, "dei_EntityRegistrantName": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityRegistrantName", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Registrant Name", "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC." } } }, "auth_ref": [ "r2" ] }, "dei_Security12gTitle": { "xbrltype": "securityTitleItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Security12gTitle", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Title of 12(g) Security", "documentation": "Title of a 12(g) registered security." } } }, "auth_ref": [ "r5" ] }, "dei_EntityEmergingGrowthCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityEmergingGrowthCompany", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Emerging Growth Company", "documentation": "Indicate if registrant meets the emerging growth company criteria." } } }, "auth_ref": [ "r2" ] }, "dei_EntityTaxIdentificationNumber": { "xbrltype": "employerIdItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityTaxIdentificationNumber", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Tax Identification Number", "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS." } } }, "auth_ref": [ "r2" ] }, "dei_FormerAddressMember": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "FormerAddressMember", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Former Address [Member]", "documentation": "Former address for entity" } } }, "auth_ref": [ "r13", "r16" ] }, "dei_DocumentRegistrationStatement": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentRegistrationStatement", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Registration Statement", "documentation": "Boolean flag that is true only for a form used as a registration statement." } } }, "auth_ref": [ "r0" ] }, "dei_WrittenCommunications": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "WrittenCommunications", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Written Communications", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act." } } }, "auth_ref": [ "r20" ] }, "dei_EntityInteractiveDataCurrent": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityInteractiveDataCurrent", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Interactive Data Current", "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files)." } } }, "auth_ref": [ "r18" ] }, "dei_EntityPublicFloat": { "xbrltype": "monetaryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityPublicFloat", "crdr": "credit", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Public Float", "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter." } } }, "auth_ref": [] }, "dei_AnnualInformationForm": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AnnualInformationForm", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Annual Information Form", "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form." } } }, "auth_ref": [ "r15" ] }, "dei_DocumentQuarterlyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentQuarterlyReport", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Quarterly Report", "documentation": "Boolean flag that is true only for a form used as an quarterly report." } } }, "auth_ref": [ "r12" ] }, "dei_SecurityReportingObligation": { "xbrltype": "securityReportingObligationItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "SecurityReportingObligation", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Security Reporting Obligation", "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act." } } }, "auth_ref": [ "r9" ] }, "dei_DocumentTransitionReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentTransitionReport", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Transition Report", "documentation": "Boolean flag that is true only for a form used as a transition report." } } }, "auth_ref": [ "r17" ] }, "dei_DocumentShellCompanyEventDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyEventDate", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Event Date", "documentation": "Date of event requiring a shell company report." } } }, "auth_ref": [ "r14" ] }, "dei_PreCommencementTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementTenderOffer", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act." } } }, "auth_ref": [ "r8" ] }, "dei_EntityAddressAddressLine3": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine3", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line Three", "documentation": "Address Line 3 such as an Office Park" } } }, "auth_ref": [] }, "dei_EntityCommonStockSharesOutstanding": { "xbrltype": "sharesItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCommonStockSharesOutstanding", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Common Stock, Shares Outstanding", "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument." } } }, "auth_ref": [] }, "dei_EntityAddressesTable": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesTable", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses [Table]", "documentation": "Container of address information for the entity" } } }, "auth_ref": [ "r2" ] }, "dei_DocumentType": { "xbrltype": "submissionTypeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentType", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Type", "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'." } } }, "auth_ref": [] }, "dei_PreCommencementIssuerTenderOffer": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "PreCommencementIssuerTenderOffer", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Pre-commencement Issuer Tender Offer", "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act." } } }, "auth_ref": [ "r7" ] }, "dei_EntityFilerCategory": { "xbrltype": "filerCategoryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFilerCategory", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Filer Category", "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [ "r2" ] }, "dei_EntityAddressesAddressTypeAxis": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressesAddressTypeAxis", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Addresses, Address Type [Axis]", "documentation": "The axis of a table defines the relationship between the domain members or categories in the table and the line items or concepts that complete the table." } } }, "auth_ref": [] }, "dei_EntityFileNumber": { "xbrltype": "fileNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityFileNumber", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity File Number", "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen." } } }, "auth_ref": [] }, "dei_DocumentPeriodStartDate": { "xbrltype": "dateItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentPeriodStartDate", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Period Start Date", "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format." } } }, "auth_ref": [] }, "dei_AmendmentDescription": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentDescription", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Description", "documentation": "Description of changes contained within amended document." } } }, "auth_ref": [] }, "dei_DocumentShellCompanyReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentShellCompanyReport", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Shell Company Report", "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act." } } }, "auth_ref": [ "r14" ] }, "dei_EntityAddressCountry": { "xbrltype": "countryCodeItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCountry", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Country", "documentation": "ISO 3166-1 alpha-2 country code." } } }, "auth_ref": [] }, "dei_EntityCurrentReportingStatus": { "xbrltype": "yesNoItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCurrentReportingStatus", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Current Reporting Status", "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure." } } }, "auth_ref": [] }, "dei_EntityCentralIndexKey": { "xbrltype": "centralIndexKeyItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityCentralIndexKey", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Central Index Key", "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK." } } }, "auth_ref": [ "r2" ] }, "dei_CurrentFiscalYearEndDate": { "xbrltype": "gMonthDayItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CurrentFiscalYearEndDate", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Current Fiscal Year End Date", "documentation": "End date of current fiscal year in the format --MM-DD." } } }, "auth_ref": [] }, "dei_Extension": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "Extension", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Extension", "documentation": "Extension number for local phone number." } } }, "auth_ref": [] }, "dei_OtherReportingStandardItemNumber": { "xbrltype": "otherReportingStandardItemNumberItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "OtherReportingStandardItemNumber", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Other Reporting Standard Item Number", "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS." } } }, "auth_ref": [ "r14" ] }, "dei_DocumentAnnualReport": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentAnnualReport", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Annual Report", "documentation": "Boolean flag that is true only for a form used as an annual report." } } }, "auth_ref": [ "r11", "r14", "r15" ] }, "dei_EntityShellCompany": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityShellCompany", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Shell Company", "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act." } } }, "auth_ref": [ "r2" ] }, "dei_EntityIncorporationStateCountryCode": { "xbrltype": "edgarStateCountryItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityIncorporationStateCountryCode", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Incorporation, State or Country Code", "documentation": "Two-character EDGAR code representing the state or country of incorporation." } } }, "auth_ref": [] }, "dei_LocalPhoneNumber": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "LocalPhoneNumber", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Local Phone Number", "documentation": "Local phone number for entity." } } }, "auth_ref": [] }, "dei_AddressTypeDomain": { "xbrltype": "domainItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AddressTypeDomain", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "documentation": "An entity may have several addresses for different purposes and this domain represents all such types." } } }, "auth_ref": [] }, "dei_EntityAddressAddressLine1": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressAddressLine1", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, Address Line One", "documentation": "Address Line 1 such as Attn, Building Name, Street Name" } } }, "auth_ref": [] }, "dei_DocumentFiscalYearFocus": { "xbrltype": "gYearItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "DocumentFiscalYearFocus", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Document Fiscal Year Focus", "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006." } } }, "auth_ref": [] }, "dei_EntityAddressStateOrProvince": { "xbrltype": "stateOrProvinceItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressStateOrProvince", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, State or Province", "documentation": "Name of the state or province." } } }, "auth_ref": [] }, "dei_CoverAbstract": { "xbrltype": "stringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "CoverAbstract", "lang": { "en-us": { "role": { "documentation": "Cover page." } } }, "auth_ref": [] }, "dei_EntityAddressCityOrTown": { "xbrltype": "normalizedStringItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityAddressCityOrTown", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Address, City or Town", "documentation": "Name of the City or Town" } } }, "auth_ref": [] }, "dei_AmendmentFlag": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "AmendmentFlag", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Amendment Flag", "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission." } } }, "auth_ref": [] }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "xbrltype": "booleanItemType", "nsuri": "http://xbrl.sec.gov/dei/2023", "localname": "EntityBankruptcyProceedingsReportingCurrent", "presentation": [ "http://psychemedics.com/role/Cover" ], "lang": { "en-us": { "role": { "label": "Entity Bankruptcy Proceedings, Reporting Current", "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element." } } }, "auth_ref": [ "r6" ] } } } }, "std_ref": { "r0": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12" }, "r1": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b" }, "r2": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-2" }, "r3": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "b-23" }, "r4": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "d1-1" }, "r5": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12", "Subsection": "g" }, "r6": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "12, 13, 15d" }, "r7": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "13e", "Subsection": "4c" }, "r8": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "14d", "Subsection": "2b" }, "r9": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Number": "240", "Section": "15", "Subsection": "d" }, "r10": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Exchange Act", "Section": "14a", "Number": "240", "Subsection": "12" }, "r11": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-K", "Number": "249", "Section": "310" }, "r12": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "240", "Section": "308", "Subsection": "a" }, "r13": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 10-Q", "Number": "249", "Section": "308", "Subsection": "a" }, "r14": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 20-F", "Number": "249", "Section": "220", "Subsection": "f" }, "r15": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 40-F", "Number": "249", "Section": "240", "Subsection": "f" }, "r16": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Form 8-K", "Number": "249", "Section": "308" }, "r17": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Section": "13", "Subsection": "a-1" }, "r18": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Regulation S-T", "Number": "232", "Section": "405" }, "r19": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "405" }, "r20": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "230", "Section": "425" }, "r21": { "role": "http://www.xbrl.org/2003/role/presentationRef", "Publisher": "SEC", "Name": "Securities Act", "Number": "7A", "Section": "B", "Subsection": "2" } } } ZIP 14 0001171843-24-000431-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001171843-24-000431-xbrl.zip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end